From Diagnosis to Management: Addressing Gaps in Wilson Disease Care

Although Wilson disease is considered a rare condition, clinicians at a recent HCPLive clinical forum convened by Lance Stein, MD, transplant hepatologist and the medical director of Piedmont’s Hepatology and Liver Transplant Program, emphasized that its true burden may be underestimated due to frequent delays and missed diagnoses. The discussion brought together hepatologists to examine real-world challenges in recognizing and managing the disease, with a focus on diagnostic uncertainty, treatment strategies, and long-term care.

Participants noted that many clinicians encounter only a handful of cases throughout their careers, contributing to limited familiarity and variability in practice. Even among specialists, experience is often based on a small number of patients, underscoring the importance of shared clinical insights and case-based learning.

A Disease With Many Faces

A central theme of the discussion was the highly variable presentation of Wilson disease. Caused by mutations in the ATP7B gene leading to impaired copper metabolism, the disease can manifest across a wide clinical spectrum, including hepatic, neurologic, and psychiatric symptoms.

Panelists emphasized that this heterogeneity frequently complicates diagnosis. Patients may present with nonspecific liver abnormalities that resemble more common conditions such as fatty liver disease or autoimmune hepatitis, particularly in younger individuals. Others may present primarily with neurologic or psychiatric symptoms, sometimes without any overt liver disease, making recognition even more difficult.

In some cases, diagnosis is made only after significant disease progression, including cirrhosis or acute liver failure. Clinicians shared experiences of patients who were diagnosed late in the disease course and, in some cases, even after liver transplantation, highlighting the consequences of delayed recognition.

Persistent Diagnostic Challenges

Despite established diagnostic tools, identifying Wilson disease remains challenging in practice. Forum participants discussed the limitations of commonly used tests, including ceruloplasmin levels, which may be normal in certain clinical contexts or misleading in acute illness.

As a result, clinicians often rely on a combination of tests, including 24-hour urinary copper excretion and, increasingly, genetic testing. However, even these approaches can yield ambiguous results, particularly in patients with atypical presentations or discordant findings.

Panelists emphasized the importance of maintaining a high index of suspicion, especially in younger patients with unexplained liver disease or atypical clinical features. Several noted that misdiagnosis or delayed diagnosis is common, particularly when symptoms overlap with more prevalent conditions or when extrahepatic manifestations predominate.

Treatment Strategies and Clinical Nuance

Once diagnosed, management of Wilson disease centers on reducing copper accumulation through chelation therapy or blocking copper absorption. Chelating agents such as D-penicillamine and trientine are commonly used to promote copper excretion, while zinc therapy may be used to reduce intestinal absorption, particularly in maintenance settings.

Treatment selection often depends on disease severity and clinical presentation. In acute or severe cases, particularly those involving liver failure, more aggressive therapy is required. Liver transplantation remains a definitive treatment option in patients with acute liver failure or decompensated cirrhosis and is unique in that it effectively corrects the underlying metabolic defect.

However, panelists noted that treatment comes with its own set of challenges. Rapid copper removal during chelation can sometimes worsen neurologic symptoms, requiring careful titration and monitoring. Additionally, psychiatric manifestations may persist even after treatment, further complicating management decisions.

The Challenge of Long-Term Management

Beyond initial treatment, long-term management of Wilson disease presents additional hurdles. Lifelong therapy is required to maintain copper balance, and adherence can be difficult, particularly in younger patients or those with psychiatric comorbidities.

Clinicians highlighted real-world challenges such as medication tolerability, access, and lifestyle factors that may affect adherence. Treatment regimens may need to be adjusted over time, including transitions between chelators and maintenance therapies such as zinc.

Family screening was also emphasized as a critical component of care, given the genetic nature of the disease. Early identification of affected individuals can allow for timely intervention before the onset of significant organ damage.

Looking Ahead: Opportunities for Improvement

The forum discussion underscored that while effective treatments for Wilson disease exist, improving outcomes will depend on earlier recognition and more consistent application of diagnostic strategies.

Participants highlighted the need for increased awareness across specialties, particularly among clinicians who may encounter atypical presentations, including neurologists and psychiatrists. Greater use of genetic testing and improved diagnostic algorithms may also help reduce delays.

Ultimately, the discussion reflected both the progress and the ongoing challenges in managing this rare but potentially life-threatening disease. For clinicians, maintaining vigilance and leveraging a multidisciplinary approach may be key to improving detection and long-term outcomes in Wilson disease.

References

1. Wilson Disease Association. Wilson Disease. Published August 13, 2021. Accessed April 16, 2026. https://wilsondisease.org/do-i-have-wilson-disease/?gad_source=1&gad_campaignid=16684019432&gbraid=0AAAAADN9hfNH0Qklo1N7KKX3qO0womQLJ&gclid=CjwKCAiAw9vIBhBBEiwAraSATuJdNxoP57_7zjL0DUUF0B9EceR3whBrdSIFmutmQSsj2E3BL4nQkhoC-xwQAvD_BwE

2. NIDDK. Diagnosis of Wilson Disease. October 2018. Accessed April 16, 2026. https://www.niddk.nih.gov/health-information/liver-disease/wilson-disease/diagnosis